Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  09/28/2007
 
Trade Name:  Lamisil Oral Granules
 
Generic or Proper Name (*):  terbinafine
 
Indications Studied:  Tinea capitis
 
Therapeutic Category:  Antifungal, topical
 
Ages Studied:  3-12 years
 
Study #:  2
 
Study Type:  Efficacy/Safety
 
Study Design:  Double-Blind/Active Control/Parallel Group
 
No Patients:  747
 
No Centers:  74
 
No Countries:  7
 
BPCA(B), PREA(P):  B
 
Asian:  1
 
Black:  320
 
Other:  284
 
White:  142
 
Native Hawaiian or Pacific Islander:  0
 
American Indian/Alaska Native:  0
 
Hispanic/Latino:  0
 
Non-Hispanic/Non Latino:  0
 
Countries:  Canada(7), Colombia(9), Egypt(3), Peru(5), South Africa (2), US(44), Venezuela(4)
 
-
-